STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
6 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
|
Mar. 09, 2026 |
Mar. 04, 2026 |
Jun. 17, 2025 |
Jun. 03, 2025 |
May 08, 2025 |
Mar. 08, 2025 |
Mar. 03, 2025 |
Feb. 24, 2025 |
Mar. 28, 2024 |
Nov. 17, 2023 |
Nov. 15, 2023 |
May 25, 2023 |
Aug. 03, 2022 |
Aug. 01, 2022 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Sep. 30, 2024 |
Feb. 24, 2025 |
Jan. 01, 2026 |
Dec. 31, 2025 |
May 22, 2025 |
Mar. 22, 2025 |
Jan. 01, 2025 |
Dec. 23, 2024 |
May 31, 2024 |
Mar. 25, 2024 |
Feb. 14, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
70,000,000
|
150,000,000
|
|
|
|
150,000,000
|
|
|
|
|
150,000,000
|
150,000,000
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000,000
|
30,000,000
|
|
|
|
30,000,000
|
|
|
|
|
30,000,000
|
30,000,000
|
|
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
| Commissions and other issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,995,041
|
|
|
$ 2,060,041
|
$ 381,293
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222,758
|
30,751
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liability |
|
|
$ 105,154
|
|
|
|
|
|
|
|
|
|
|
|
$ 69,829
|
|
$ 260,602
|
|
(185,126)
|
(565,387)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant liability classified instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,307,269
|
|
|
|
1,307,269
|
|
|
|
|
$ 1,492,395
|
|
|
|
|
|
|
|
|
|
| Proceeds from warrant exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
328,924
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,680,425
|
|
|
|
16,680,425
|
|
|
|
|
12,878,381
|
|
|
|
|
|
|
|
|
|
| Options contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,423,891
|
|
|
|
11,423,891
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,909,518
|
3,066,519
|
|
|
|
3,066,519
|
|
|
|
6,458,889
|
|
|
|
2,250,000
|
|
|
|
|
2,838,668
|
1,956,993
|
| Percentage of increase in stock outstanding fully diluted |
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 Stock Option Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,752,945
|
|
|
|
1,752,945
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amended And Restated 2020 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,503,589
|
|
|
|
3,503,589
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 343,735
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
2.82%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
|
|
|
|
|
77.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consulting Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 19,830
|
$ 31,570
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,492
|
18,040
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unvested shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
0
|
|
0
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted-average grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.00
|
$ 2.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unrecognized compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,887,064
|
|
|
|
$ 5,887,064
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unrecognized compensation expense, recognized period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 year 7 months 24 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Performance Shares [Member] | 2021 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Performance Shares [Member] | 2021 Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Tranche One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Performance Shares [Member] | 2021 Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Tranche Two [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of increase in stock outstanding fully diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
793,429
|
666,323
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock |
|
|
219,283
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from warrant exercise |
|
|
$ 328,924
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,348
|
17,083
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum [Member] | Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years 1 month 2 days
|
6 years 29 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| At-The-Market Offering Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commissions and other issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 61,132
|
$ 130,220
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock sold |
|
|
|
|
719,999
|
|
952,633
|
1,810,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock per share |
|
|
|
|
$ 1.50
|
|
$ 1.50
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
|
| Commissions and other issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
115,493
|
$ 74,448
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock |
|
|
|
|
719,999
|
719,999
|
952,633
|
1,810,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,810,000
|
|
|
|
|
|
|
437,031
|
|
|
|
|
| Gross proceeds from private placement |
|
|
|
$ 700,000
|
$ 1,080,000.00
|
|
$ 1,400,000
|
$ 2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
|
$ 2.05
|
$ 1.50
|
$ 1.85
|
$ 1.87
|
$ 2.55
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.87
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants term |
|
|
|
5 years
|
6 years
|
|
6 years
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expiration date |
|
|
|
Jun. 03, 2030
|
May 08, 2031
|
May 08, 2031
|
Mar. 03, 2031
|
Feb. 24, 2031
|
Sep. 28, 2029
|
|
|
|
|
|
|
|
|
|
|
|
|
Feb. 24, 2031
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights exercisable period |
|
|
|
Dec. 03, 2025
|
|
May 08, 2026
|
Mar. 03, 2026
|
|
Sep. 28, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
Feb. 24, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants value |
|
|
|
|
|
|
|
|
$ 1,190,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
5 years 6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
4.20%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock sold |
|
|
|
|
|
|
|
|
578,643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | Amendment of Warrant Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
89,445
|
|
|
|
$ 89,445
|
|
|
|
|
$ 117,613
|
|
|
|
|
$ 1,011,562
|
|
|
|
|
| Change in fair value of warrant liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,425
|
|
4,564
|
|
28,168
|
$ 50,063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant liability classified instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141,612
|
|
|
|
141,612
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | 2021 Equity Incentive Plan [Member] | Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock |
|
|
|
33,333
|
|
86,666
|
58,333
|
123,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
123,333
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | 2021 Equity Incentive Plan [Member] | Affiliated and Nonaffiliated Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock |
|
|
|
|
|
|
|
1,686,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,686,667
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | 2021 Equity Incentive Plan [Member] | Non-affiliated Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock |
|
|
|
429,999
|
|
633,333
|
894,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | Black Sholes Method [Member] | Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants value |
|
|
|
$ 43,358
|
|
$ 133,131
|
$ 80,894
|
$ 176,680
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 176,680
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value assumptions, contractual term |
|
|
|
5 years
|
|
6 years
|
6 years
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk free interest rate |
|
|
|
4.04%
|
|
4.09%
|
3.97%
|
4.23%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
95.00%
|
|
95.00%
|
95.00%
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | Black Sholes Method [Member] | Affiliated and Nonaffiliated Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value assumptions, contractual term |
|
|
|
|
|
|
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
4.23%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liability |
|
|
|
|
|
|
|
$ 2,416,223
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | Black Sholes Method [Member] | Non-affiliated Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk free interest rate |
|
|
|
4.04%
|
|
4.09%
|
3.97%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
95.00%
|
|
95.00%
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liability |
|
|
|
$ 559,324
|
|
$ 972,890
|
$ 1,240,185
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock sold |
|
|
|
463,332
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock per share |
|
|
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock |
|
|
|
463,332
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
$ 1.71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Confidentially Marketed Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock sold |
2,005,875
|
20,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock per share |
$ 1.50
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering |
$ 3,009,000
|
$ 30,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commissions paid |
150,000
|
1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commissions and other issuance costs |
16,000
|
329,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from offering |
$ 2,843,000
|
$ 28,171,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expiration date |
|
|
|
|
|
|
|
|
|
|
|
|
|
Jul. 27, 2027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights exercisable period |
|
|
|
|
|
|
|
|
|
|
|
|
|
Jan. 23, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IPO [Member] | Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,278
|
|
|
|
5,278
|
|
|
|
|
27,455
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
954
|
|
5,808
|
|
22,177
|
32,076
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Over-Allotment Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase common stock |
|
|
|
|
|
|
|
|
|
2,424,243
|
169,697
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
|
|
|
|
|
|
$ 1.86
|
$ 2.06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expiration date |
|
|
|
|
|
|
|
|
|
|
Nov. 15, 2028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights exercisable period |
|
|
|
|
|
|
|
|
|
|
Nov. 15, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants value |
|
|
|
|
|
|
|
|
|
$ 1,903,915
|
$ 123,811
|
|
|
|
93,320
|
|
|
|
93,320
|
|
|
|
|
130,553
|
|
|
|
|
|
|
|
|
|
| Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
5 years 4 months 17 days
|
4 years 10 months 17 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
|
3.85%
|
3.84%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
|
|
90.00%
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,919
|
|
65,546
|
|
37,233
|
15,741
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
909,091
|
|
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering [Member] | Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants value |
|
|
|
|
|
|
|
|
|
$ 2,815,970
|
|
|
|
|
1,119,226
|
|
|
|
1,119,226
|
|
|
|
|
$ 1,216,774
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 94,219
|
|
$ 246,105
|
|
$ 97,548
|
$ 433,443
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
458,726
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase in equity on exercise of warrant liability |
|
|
|
|
|
|
|
|
|
$ 2,815,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H.C. Wainwright & Co., LLC [Member] | At-The-Market Offering Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
| Number of common stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
666,323
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,521,091
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commissions paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,633
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commissions and other issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
84,587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,390,871
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H.C. Wainwright & Co., LLC [Member] | At-The-Market Offering Agreement [Member] | Maximum [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate offering price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,200,000
|
|
$ 30,000,000
|
|
$ 4,950,000
|
$ 1,445,000
|
|
|